December 23, 2024 09:50 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle
Glenmark launches Tavulus for COPD treatment in Spain

Glenmark launches Tavulus for COPD treatment in Spain

Oct 11, 2021, at 07:18 pm

Mumbai/UNI: Pharma major Glenmark Pharma Monday announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus in Spain for the treatment of chronic obstructive pulmonary disease (COPD).

Glenmark Pharma receives ANDA approval for Fingolimod Capsules, 0.5 mg

Glenmark Pharma receives ANDA approval for Fingolimod Capsules, 0.5 mg

Jun 19, 2020, at 04:44 pm

Mumbai/UNI:  Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fingolimod Capsules, 0.5 mg, the generic version of Gilenya Capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation.